Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2025-01-24 00:00:00 ET · period of report 2025-01-22 · accession 0000950170-25-008970 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-24 | 2025-01-22 | TMCI | Hair Mark | CFO | A - Grant | $0.00 | +187.5K | 546.8K | +52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-22 | A | A | 187,500 | $0.00 | 546,821 | D | — | — | (F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date. (F2) Holdings include 504,758 restricted stock units and reflect that the Reporting Person no longer has any indirect ownership through dependent children. |